SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-140318

Patient #034

Hasnah · 70y · Female · Malay · BMI 25.8 · ECOG 2
SVMC - Sunway Velocity · Medical Oncology · Dr. Chong Boon Keat
IVB (T4, N3, M1c)Stable
ALK fusion
Clinical storyline

Hasnah, a 70-year-old Malay female (former, 14 pack-years, ECOG 2), presented in 2025-11 with hemoptysis (blood-streaked sputum). Workup confirmed Adenocarcinoma (Stage IV, ALK fusion). The MDT recommended first-line alectinib. Current status: Stable.

HPE Results
Poorly differentiated adenocarcinoma
Clinical Stage
IVB (T4, N3, M1c)
Pathological Stage
IVB (T4, N3, M1c)
Adenocarcinoma Subtype
Poorly differentiated adenocarcinoma
CEA (ng/mL)
NA
Tumor (CT/PET)
8.7 cm
PET SUV
10.77
NGS Results
ALK fusion positive